Trial
NCT02955147
Ustekinumab for the Treatment of Giant Cell Arteritis
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Massachusetts General Hospital
Collaborators
—
Condition
Giant Cell Arteritis
Intervention
Ustekinumab
Why stopped
Inefficacy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-06-12